Can AI Be Trusted to Guide Pharmacogenomics Decisions? Sherpa Rx
Artificial intelligence is beginning to find its footing in one of medicine’s most nuanced frontiers: pharmacogenomics — the science of matching medications to…
Artificial intelligence is beginning to find its footing in one of medicine’s most nuanced frontiers: pharmacogenomics — the science of matching medications to…
In May 2024, the U.S. Food and Drug Administration (FDA) published a final rule that would bring laboratory-developed tests (LDTs) explicitly under the…
Pharmacogenomics—the study of how genes affect a person’s response to drugs—is transforming modern medicine. By tailoring drug treatments based on genetic profiles, it…
When you talk to Dr. Gualberto Ruaño, you don’t just hear about science — you hear about purpose. A physician, geneticist, and entrepreneur,…
Grand View Research has just released its latest report on the pharmacogenomics technology market, offering fresh insights into one of the fastest-growing areas…
Pharmacogenetic testing has emerged as one of the most exciting frontiers in personalized medicine. By analyzing a patient’s genetic makeup, these tests promise…
Learn how to build a business case for a Pharmacogenomics Program in Your Hospital with our step-by-step guide for clinical champions.
The promise of precision medicine lies in its ability to tailor treatments to the genetic makeup of each patient. Pharmacogenomics is central to…
Explore Venture Capital Trends in Pharmacogenomics and understand the current investment landscape for PGx startups and technologies.
Get the facts on Reimbursement for Pharmacogenomic Testing. Our case study offers a practical guide for providers and labs on navigating insurance and billing.
End of content
End of content
Join Our Insider’s Circle! Stay up to Date with the latest in PGx